EVOK News

Ritter Pharmaceuticals, which is developing an oral therapy that reduces the symptoms of lactose intolerance, lowered the proposed offer price for its upcoming IPO on Friday. The Los Angeles, CA-based company now plans to raise $20 million by offering 4...read more

Last week saw high levels of activity in the IPO market, as eleven companies priced, making this month the first September to have 20 deals since September of 2000. Health care and technology companies continued to dominate the space, with nine of the...read more

Evoke Pharma, which is developing drugs to treat gastrointestinal disorders and diseases, raised $25 million by offering 2.1 million shares at $12, the low end of the range of $12 to $14. Evoke Pharma plans to list on the NASDAQ under the symbol EVOK. Evoke...read more

The following IPOs are expected to price this week: Applied Optoelectronics (AAOI), a leading fiber-optic networking products provider, plans to raise $50 million by...read more